IFM Investors Pty Ltd acquired a new stake in Cigna Corporation (NYSE:CI) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 7,113 shares of the health services provider’s stock, valued at approximately $1,330,000.

Several other hedge funds have also made changes to their positions in the stock. Saratoga Research & Investment Management purchased a new position in Cigna in the third quarter worth approximately $112,000. Riverhead Capital Management LLC lifted its stake in Cigna by 159.3% in the second quarter. Riverhead Capital Management LLC now owns 5,511 shares of the health services provider’s stock worth $923,000 after acquiring an additional 3,386 shares during the last quarter. Pacer Advisors Inc. lifted its stake in Cigna by 3.0% in the second quarter. Pacer Advisors Inc. now owns 5,581 shares of the health services provider’s stock worth $934,000 after acquiring an additional 165 shares during the last quarter. Norinchukin Bank The lifted its stake in Cigna by 6.4% in the second quarter. Norinchukin Bank The now owns 17,766 shares of the health services provider’s stock worth $2,974,000 after acquiring an additional 1,062 shares during the last quarter. Finally, Seven Eight Capital LP lifted its stake in Cigna by 504.4% in the second quarter. Seven Eight Capital LP now owns 27,200 shares of the health services provider’s stock worth $4,553,000 after acquiring an additional 22,700 shares during the last quarter. Hedge funds and other institutional investors own 87.85% of the company’s stock.

A number of research analysts recently issued reports on the stock. Piper Jaffray Companies reiterated a “buy” rating and issued a $191.00 price target on shares of Cigna in a research note on Sunday, September 17th. BidaskClub upgraded shares of Cigna from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 18th. Royal Bank of Canada reiterated an “outperform” rating and issued a $220.00 price target (up previously from $185.00) on shares of Cigna in a research note on Friday, November 3rd. Credit Suisse Group assumed coverage on shares of Cigna in a research report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price objective for the company. Finally, Morgan Stanley boosted their price objective on shares of Cigna from $188.00 to $195.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $201.50.

In other news, EVP Alan Muney sold 15,345 shares of Cigna stock in a transaction on Monday, November 27th. The shares were sold at an average price of $200.80, for a total value of $3,081,276.00. Following the transaction, the executive vice president now directly owns 28,457 shares of the company’s stock, valued at approximately $5,714,165.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Mary T. Hoeltzel sold 575 shares of Cigna stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $197.03, for a total transaction of $113,292.25. Following the completion of the transaction, the chief accounting officer now directly owns 2,499 shares in the company, valued at $492,377.97. The disclosure for this sale can be found here. Insiders sold a total of 34,724 shares of company stock worth $6,934,822 over the last ninety days. Corporate insiders own 1.30% of the company’s stock.

Shares of Cigna Corporation (CI) opened at $208.48 on Wednesday. The firm has a market cap of $51,568.34, a P/E ratio of 20.15, a PEG ratio of 1.60 and a beta of 0.50. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37. Cigna Corporation has a 12-month low of $131.26 and a 12-month high of $212.46.

Cigna (NYSE:CI) last issued its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, topping the consensus estimate of $2.36 by $0.47. The business had revenue of $10.38 billion during the quarter, compared to the consensus estimate of $10.17 billion. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The company’s revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.94 EPS. research analysts expect that Cigna Corporation will post 10.34 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/12/13/7113-shares-in-cigna-corporation-ci-purchased-by-ifm-investors-pty-ltd.html.

About Cigna

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.